A detailed history of Cooper/Haims Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cooper/Haims Advisors, LLC holds 3,629 shares of ABT stock, worth $428,693. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,629
Previous 3,629 -0.0%
Holding current value
$428,693
Previous $377,000 9.55%
% of portfolio
0.23%
Previous 0.21%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$100.73 - $112.44 $60,438 - $67,464
-600 Reduced 14.19%
3,629 $377,000
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $1,314 - $1,451
-12 Reduced 0.28%
4,229 $480,000
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $2,519 - $2,807
25 Added 0.59%
4,241 $462,000
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $2,376 - $2,788
-25 Reduced 0.59%
4,216 $463,000
Q3 2022

Nov 01, 2022

SELL
$96.76 - $112.03 $9,579 - $11,090
-99 Reduced 2.28%
4,241 $410,000
Q2 2022

Jul 25, 2022

BUY
$102.07 - $123.37 $12,656 - $15,297
124 Added 2.94%
4,340 $472,000
Q1 2022

May 09, 2022

BUY
$114.02 - $139.04 $57,010 - $69,520
500 Added 13.46%
4,216 $499,000
Q3 2021

Oct 21, 2021

SELL
$116.66 - $129.06 $11,666 - $12,906
-100 Reduced 2.62%
3,716 $439,000
Q2 2021

Aug 04, 2021

BUY
$105.79 - $124.53 $10,579 - $12,453
100 Added 2.69%
3,816 $442,000
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $291,743 - $324,778
3,716 New
3,716 $323,000
Q3 2019

Nov 07, 2019

SELL
$81.84 - $88.74 $255,013 - $276,513
-3,116 Closed
0 $0
Q2 2019

Jul 26, 2019

SELL
$72.88 - $85.0 $72,880 - $85,000
-1,000 Reduced 24.3%
3,116 $262,000
Q1 2019

Apr 29, 2019

SELL
$66.22 - $80.06 $315,538 - $381,485
-4,765 Reduced 53.65%
4,116 $329,000
Q1 2019

Apr 26, 2019

BUY
$66.22 - $80.06 $315,538 - $381,485
4,765 Added 115.77%
8,881 $710,000
Q3 2018

Nov 09, 2018

SELL
$60.81 - $73.36 $1,033 - $1,247
-17 Reduced 0.41%
4,116 $302,000
Q2 2018

Aug 01, 2018

BUY
$57.57 - $63.54 $237,936 - $262,610
4,133 New
4,133 $252,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cooper/Haims Advisors, LLC Portfolio

Follow Cooper/Haims Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper/Haims Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cooper/Haims Advisors, LLC with notifications on news.